MX363622B - Nuevos derivados de amidinourea macrociclica, metodos de preparacion y usos de los mismos como inhibidores de quitinasa. - Google Patents
Nuevos derivados de amidinourea macrociclica, metodos de preparacion y usos de los mismos como inhibidores de quitinasa.Info
- Publication number
- MX363622B MX363622B MX2015017446A MX2015017446A MX363622B MX 363622 B MX363622 B MX 363622B MX 2015017446 A MX2015017446 A MX 2015017446A MX 2015017446 A MX2015017446 A MX 2015017446A MX 363622 B MX363622 B MX 363622B
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- methods
- chitinase inhibitors
- new macrocyclic
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/24—Y being a hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a derivados de amidinourea macricíclica de la fórmula 8, métodos de preparación y usos de los mismos, composiciones farmacéuticas en particular para ser utilizadas como inhibidores de la quitinasa en el tratamiento de una infección micótica.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361836401P | 2013-06-18 | 2013-06-18 | |
PCT/EP2014/062896 WO2014202697A1 (en) | 2013-06-18 | 2014-06-18 | New macrocyclic amidinourea derivatives, methods of preparation and uses thereof as chitinase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015017446A MX2015017446A (es) | 2016-08-12 |
MX363622B true MX363622B (es) | 2019-03-28 |
Family
ID=50979767
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015017446A MX363622B (es) | 2013-06-18 | 2014-06-18 | Nuevos derivados de amidinourea macrociclica, metodos de preparacion y usos de los mismos como inhibidores de quitinasa. |
Country Status (10)
Country | Link |
---|---|
US (1) | US10071975B2 (es) |
EP (1) | EP3010896B1 (es) |
JP (1) | JP6586416B2 (es) |
CN (1) | CN105612147B (es) |
AU (1) | AU2014283281C1 (es) |
BR (1) | BR112015031820A2 (es) |
CA (1) | CA2915767A1 (es) |
MX (1) | MX363622B (es) |
PT (1) | PT3010896T (es) |
WO (1) | WO2014202697A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9135200B2 (en) | 2013-06-28 | 2015-09-15 | Futurewei Technologies, Inc. | System and method for extended peripheral component interconnect express fabrics |
EP3854789A1 (en) | 2020-01-22 | 2021-07-28 | Cygnet Biosciences B.V. | Macrocyclic compounds useful as chitinase inhibitors |
CN113773233B (zh) * | 2021-09-18 | 2022-05-06 | 中国农业大学 | 一种甲基胍基脲衍生物及其制备方法与应用 |
CN115754090B (zh) * | 2022-12-15 | 2023-08-29 | 华夏生生药业(北京)有限公司 | 一种lc-ms检测氟康唑相关杂质的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1114155A (en) * | 1964-08-24 | 1968-05-15 | Evans Medical Ltd | Guanidino derivatives |
JP5733988B2 (ja) * | 2008-03-13 | 2015-06-10 | ユニバーシタ・デグリ・スタディ・ディ・シエナ | 直鎖及び環式グアニジン誘導体、その調製方法及び使用 |
-
2014
- 2014-06-18 CA CA2915767A patent/CA2915767A1/en not_active Abandoned
- 2014-06-18 WO PCT/EP2014/062896 patent/WO2014202697A1/en active Application Filing
- 2014-06-18 AU AU2014283281A patent/AU2014283281C1/en not_active Ceased
- 2014-06-18 JP JP2016520477A patent/JP6586416B2/ja not_active Expired - Fee Related
- 2014-06-18 EP EP14731625.1A patent/EP3010896B1/en active Active
- 2014-06-18 BR BR112015031820A patent/BR112015031820A2/pt active Search and Examination
- 2014-06-18 US US14/899,872 patent/US10071975B2/en not_active Expired - Fee Related
- 2014-06-18 MX MX2015017446A patent/MX363622B/es unknown
- 2014-06-18 PT PT147316251T patent/PT3010896T/pt unknown
- 2014-06-18 CN CN201480045663.3A patent/CN105612147B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
MX2015017446A (es) | 2016-08-12 |
BR112015031820A2 (pt) | 2017-07-25 |
JP6586416B2 (ja) | 2019-10-02 |
CN105612147A (zh) | 2016-05-25 |
PT3010896T (pt) | 2018-03-07 |
AU2014283281A1 (en) | 2016-02-04 |
CN105612147B (zh) | 2018-06-05 |
WO2014202697A1 (en) | 2014-12-24 |
CA2915767A1 (en) | 2014-12-24 |
AU2014283281C1 (en) | 2019-01-24 |
EP3010896B1 (en) | 2017-11-01 |
US10071975B2 (en) | 2018-09-11 |
AU2014283281B2 (en) | 2018-10-04 |
US20160137617A1 (en) | 2016-05-19 |
JP2016522236A (ja) | 2016-07-28 |
EP3010896A1 (en) | 2016-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019005379A (es) | Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo. | |
PH12015501843A1 (en) | Novel pyrazol derivatives | |
UA114656C2 (uk) | Похідні піридину | |
MY176814A (en) | Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis | |
MX2015008627A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
MX2016006432A (es) | Tetrahidro-benzodiazepinonas. | |
MX367897B (es) | Derivados de piridazinona macrociclicos. | |
NZ628294A (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
MX2019009100A (es) | Nuevos derivados de triazolo[4,5-d]pirimidina. | |
PH12015502118A1 (en) | Pyridin-4-yl derivatives | |
MX2020001756A (es) | Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos. | |
PH12015501933B1 (en) | Novel pyridine derivatives | |
MA40583A (fr) | Nouveaux activateurs de la guanylate cyclase soluble et leur utilisation | |
PH12015501175A1 (en) | Substituted pyridopyrazines as syk inhibitors | |
CA2929436C (en) | Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases | |
MX363622B (es) | Nuevos derivados de amidinourea macrociclica, metodos de preparacion y usos de los mismos como inhibidores de quitinasa. | |
MX2015000179A (es) | Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas. | |
TN2016000490A1 (en) | Naphthyridinedione derivatives. | |
PH12015500399A1 (en) | Azaindolines | |
MX2014008918A (es) | Nuevos derivados de pirrolidina. | |
MX2015016766A (es) | Nuevos derivados de tetrazolona. |